본문 바로가기
KERD
논문KCI 등재

Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류화학

초록

Epigallocatechin gallate (EGCG) and curcumin are well known to naturally-occurring anticancer agents. The aim of this study was to verify the combined beneficial anticancer effects of curcumin and EGCG on PC3 prostate cancer cells, which are resistant to chemotherapy drugs and apoptosis inducers. EGCG showed weaker inhibitory effect on PC3 cell proliferation than two other prostate cancer cell lines, LNCaP and DU145. Co-treatment of curcumin improved antiproliferative effect of EGCG on PC3 cells. The protein expressions of p21 were significantly increased by the co-treatment of EGCG and curcumin, whereas it was not changed by the treatment with each individual compound. Moreover, treatments of EGCG and curcumin arrested both S and G2/M phases of PC3 cells. These results suggest that the enhanced inhibitory effect of EGCG on PC3 cell proliferation by curcumin was mediated by the synergic up-regulation of p21-induced growth arrest and followed cell growth arrest

Abstract

Epigallocatechin gallate (EGCG) and curcumin are well known to naturally-occurring anticancer agents. The aim of this study was to verify the combined beneficial anticancer effects of curcumin and EGCG on PC3 prostate cancer cells, which are resistant to chemotherapy drugs and apoptosis inducers. EGCG showed weaker inhibitory effect on PC3 cell proliferation than two other prostate cancer cell lines, LNCaP and DU145. Co-treatment of curcumin improved antiproliferative effect of EGCG on PC3 cells. The protein expressions of p21 were significantly increased by the co-treatment of EGCG and curcumin, whereas it was not changed by the treatment with each individual compound. Moreover, treatments of EGCG and curcumin arrested both S and G2/M phases of PC3 cells. These results suggest that the enhanced inhibitory effect of EGCG on PC3 cell proliferation by curcumin was mediated by the synergic up-regulation of p21-induced growth arrest and followed cell growth arrest

참고문헌 (35)

  1. Siegel R, "Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths", CA Cancer J Clin, 61, pp.212~236 (2011)
  2. Lange PH, "Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone", Cancer Metastasis Rev, 17, pp.331~336 (1998)
  3. Bubendorf L, "Metastatic patterns of prostate cancer: An autopsy study of 1,589patients", Hum Pathol, 31, pp.578~583 (2000)
  4. Roudier MP, "Histopathological assessment of prostate cancer bone osteoblastic metastases", J Urol, 180, pp.1154~1160 (2008)
  5. Ferlay J, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008", Int J Cancer, 127, pp.2893~2917 (2010)
  6. Vickers A, "Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials", Cancer Invest, 20, pp.1069~1079 (2002)
  7. Shimizu M, "Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases", Mol Nutr Food Res, 55, pp.832~843 (2011)
  8. Yang H, "Green tea polyphenols as proteasome inhibitors: Implication in chemoprevention", Cancer Drug Targets, 11, pp.296~306 (2011)
  9. Sintara K, "Curcumin attenuates gastric cancer induced by N-methyl-N-nitrosourea and saturated sodium chloride in rats", J Biomed Biotechnol, 2012, pp.1~8 (2012)
  10. Yang CS, "Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance", Nat Rev Cancer, 9, pp.429~439 (2009)
  11. Kim JW, "Chemoprevention of head and neck cancer with green tea polyphenols", Cancer Prev Res, 3, pp.900~909 (2010)
  12. Ahmad N, "Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells", Arch Biochem Biophys, 376, pp.338~346 (2000)
  13. Adhami VM, "Molecular targets for green tea in prostate cancer prevention", J Nutr, 133, pp.2417~2424 (2003)
  14. Borska S, "Induction of apoptosis by EGCG in selected tumour cell lines in vitro", Folia Histochem Cytobiol, 41, pp.229~232 (2003)
  15. Ahmad KA, "Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells", Mol Cancer Ther, 6, pp.1006~1012 (2007)
  16. Chung LY, "Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells", Life Sci, 68, pp.1207~1214 (2001)
  17. Hastak K, "Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate", FASEB J, 19, pp.789~791 (2005)
  18. Kuttan G, "Antitumor, anti-invasion, and antimetastatic effects of curcumin", Adv Exp Med Biol, 595, pp.173~184 (2007)
  19. Kunnumakkara AB, "Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins", Cancer Lett, 269, pp.199~225 (2008)
  20. Zhang X, "Plant natural compounds: Targeting pathways of autophagy as anti-cancer therapeutic agents", Cell Prolif, 45, pp.466~476 (2012)
  21. Shehzad A, "Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials", Arch Pharm, 343, pp.489~499 (2010)
  22. Mukhtar H, "Cancer chemoprevention:future holds in multiple agents", Toxicol Appl Pharmacol, 158, pp.207~210 (1999)
  23. McCarty MF, "Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy", Integr Cancer Ther, 3, pp.349~380 (2004)
  24. Banerjee S, "Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer", Cancer Res, 65, pp.9064~9072 (2005)
  25. Khor TO, "Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice", Cancer Res, 66, pp.613~621 (2006)
  26. Narayanan BA, "Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition", Prostate, 66, pp.257~265 (2006)
  27. Adhami VM, "Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo", Clin Cancer Res, 13, pp.1611~1619 (2007)
  28. Chou TC, "Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies", Pharmacol Rev, 58, pp.621~681 (2006)
  29. Suganuma M, "New cancer treatment strategy using combination of green tea catechins and anticancer drugs", Cancer Sci, 102, pp.317~323 (2011)
  30. Stone A, "Inhibitors of cell cycle kinases: Recent advances and future prospects as cancer therapeutics", Crit Rev, 17, pp.175~198 (2012)
  31. Chauhan DP, "Chemotherapeutic potential of curcumin for colorectal cancer", Curr Pharm, 8, pp.1695~1706 (2002)
  32. Shankar S, "Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer", Front Biosci, 12, pp.5039~5051 (2007)
  33. Saha A, "New role of(-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin", Cancer Prev Res, 3, pp.953~962 (2010)
  34. Kim S, "Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols", Nutr Cancer, 37, pp.41~48 (2000)
  35. Somers-Edgar TJ, "The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo", Int J Cancer, 122, pp.1966~1971 (2008)

관련 논문AI추천

이 간행물의 다른 논문 (10건)